dm+d

23612311000001102

Articles

Vaccination and antibiotic prescribing in patients with asplenia or splenic dysfunction in primary care

24 April 2019Following the death of a young asplenic patient in 2016 our project involves the identification and review of asplenic or hyposplenic patients in primary care,…
Search Articles

Refrigerated Storage

BexseroGlaxoSmithKline (GSK)

GlaxoSmithKline (GSK)
Bexsero
Pre-filled syringe

In the event of an inadvertent temperature excursion the following data may be used:
A maximum cumulative time of 48 hours is permitted for the vaccine to be at temperatures above 8°C through to 25°C.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.
Contact GSK in cases where the product has been exposed to temperature deviation other than described above. Refer to the current BNF for company contact details.

No, if exposed to conditions described above
Yes, if exposed to conditions described above
18 December 2019
London Medicines Information Service

Trumenba Pfizer Limited

Pfizer Limited
Trumenba
Suspension for injection in pre-filled syringe

In the event of an inadvertent temperature excursion the following data may be used:

Trumenba may be exposed to temporary elevated temperature excursions (such as a refrigerator malfunction) of up to 25°C for a cumulative period of up to 7 days.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

No
Yes
3 August 2020
London MI Service